Vertex agrees to sell cheaper Trikafta in SA

Johannesburg investment banker Cheri Nel has dropped her court case against Vertex Pharmaceuticals. She had asked the Gauteng High Court to allow generic versions of Trikafta, a cystic fibrosis medicine, to be imported to South Africa. Trikafta, a “miracle” treatment, significantly improves the lives of cystic fibrosis patients. Since its 2019 US registration, it has been effective for 90% of…

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in